Fusion Pharmaceuticals
John Valliant is the current CEO of Fusion Pharmaceuticals. John previously worked at the Centre for Probe Development and Commercialization and McMaster University.
John Valliant has a Ph.D. in Chemistry from McMaster University.
Some direct reports include Christopher Leamon - Chief Scientific Officer, Eric S. Hoffman - SVP, Business Development, and Mohit Rawat - President & Chief Business Officer.
This person is not in any offices
Fusion Pharmaceuticals
6 followers
Fusion Pharmaceuticals is a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines.